Legal Representation
Attorney
Jennifer Sheehan Anderson
USPTO Deadlines
Next Deadline
1757 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-05-21)
Due Date
May 21, 2030
Grace Period Ends
November 21, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
28 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Nov 30, 2024 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
Nov 9, 2024 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
Nov 9, 2024 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
Aug 21, 2024 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
Jul 13, 2024 | ADCH | M | CHANGE OF NAME/ADDRESS REC'D FROM IB | Loading... |
Jun 15, 2024 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
May 21, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
May 21, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Mar 5, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Mar 5, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Mar 4, 2024 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
Feb 14, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Feb 14, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Feb 14, 2024 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
Feb 14, 2024 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
Jan 26, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Jan 24, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Jan 24, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Jan 24, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Aug 29, 2023 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
Aug 9, 2023 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
Aug 9, 2023 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
Jul 5, 2023 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
Jul 4, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Jun 29, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Mar 21, 2023 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
Mar 17, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Mar 9, 2023 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Medicated adhesive devices in the nature of epicutaneous patches enabling the cutaneous or epicutaneous administration of pharmaceutical or medicated substances in dry form for humans and animals for the treatment and prevention of allergies, autoimmune, inflammatory and infectious diseases; epicutaneous patches containing powdered preparations for medical use for the treatment and prevention of allergies, autoimmune, inflammatory and infectious diseases; medicated occlusion patches in the nature of epicutaneous patches enabling the absorption of powdered medicated substances through the skin for the treatment and prevention of allergies, autoimmune, inflammatory and infectious diseases
Class 010
Medical apparatus, instruments and devices, namely, epicutaneous patches sold without medication for the cutaneous or epicutaneous administration of medicated or cosmetic substances in dry form for humans or animals; occlusion patch dispensers for medical use; medical instruments using the electrostatic properties of biocompatible media, namely, epicutaneous patches sold without medication
Class 041
Educational services for consumers and professionals in the field of immunotherapy, namely, organizing classes, seminars, programs, conferences, congresses, workshops in the field of immunotherapy; organizing and providing exhibitions for online educational purposes featuring interactive presentations and exhibitions in the field of immunotherapy; publishing periodicals, books, and guides in the field of immunotherapy; database publishing services, namely publishing of periodical journals containing printed databases in tabular form in the field of immunotherapy; providing information with respect to education in the field of immunotherapy via an online website
Class 042
Medical and scientific research in the field of immunotherapy, namely, developing scientific methods for epicutaneous immunotherapy, to try to treat and prevent autoimmune, infectious and inflammatory diseases without prior preparation of the skin other than a simple rapid cleaning in order to leave the cell structure of the skin intact; scientific research in the field of allergy treatment and care; scientific research in the field of allergy treatment for the repeated application of treatments to patients' skin without prior preparation of the skin other than a simple rapid cleaning in order to leave the cell structure of the skin intact and thus avoid the passage of allergens into the blood; allergenic drug discovery services; medical and scientific research services, namely, developing methods for treating allergies via contact between allergens and skin immune cells; medical and scientific research services, namely, developing methods for the treatment and prevention of allergies, autoimmune, infectious and inflammatory diseases by applying patches to patients' unbroken skin without prior preparation of the skin other than a simple rapid cleaning in order to leave the cell structure of the skin intact
Class 044
Medical services using desensitization methods on the principle of immunotherapy; medical treatment and prevention of allergies, inflammatory, autoimmune and infectious diseases through the administration of allergens, antigens using patches affixed to the patients' unbroken skin, thus avoiding the transfer of allergens into the blood; medical treatment and prevention of allergies, inflammatory, autoimmune and infectious diseases using epicutaneous methods of desensitization via immunotherapy; epicutaneous medical treatments and prevention of allergies, inflammatory, autoimmune and infectious diseases without prior preparation of the skin other than a simple rapid cleaning in order to leave the cell structure of the skin intact; medical consultancy in the field of desensitization to allergies with respect to desensitization to combat allergies
Classification
International Classes
005
010
041
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"TECHNOLOGIES"